Essex Woodlands Management as of June 30, 2020
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revance Therapeutics (RVNC) | 40.0 | $82M | 3.3M | 24.42 | |
| Venus Concept | 21.3 | $43M | 12M | 3.49 | |
| Eyepoint Pharmaceuticals | 15.6 | $32M | 42M | 0.76 | |
| Axogen (AXGN) | 11.0 | $23M | 2.4M | 9.24 | |
| Tela Bio (TELA) | 8.8 | $18M | 1.4M | 12.96 | |
| Medicinova Com New (MNOV) | 2.9 | $6.0M | 1.1M | 5.42 | |
| Catalyst Biosciences Com New | 0.2 | $462k | 79k | 5.88 | |
| Endologix Com New | 0.0 | $101k | 126k | 0.80 |
